Accelerated phosphatidylcholine turnover in macrophages promotes adipose tissue inflammation in obesity

  1. Kasparas Petkevicius  Is a corresponding author
  2. Sam Virtue
  3. Guillaume Bidault
  4. Benjamin Jenkins
  5. Cankut Çubuk
  6. Cecilia Morgantini
  7. Myriam Aouadi
  8. Joaquin Dopazo
  9. Mireille Serlie
  10. Albert Koulman
  11. Antonio Vidal-Puig  Is a corresponding author
  1. University of Cambridge, United Kingdom
  2. Fundacion Progreso y Salud, Spain
  3. Karolinska Institute, Sweden
  4. Amsterdam University Medical Center, Netherlands

Abstract

White adipose tissue (WAT) inflammation contributes to the development of insulin resistance in obesity. While the role of adipose tissue macrophage (ATM) pro-inflammatory signalling in the development of insulin resistance has been established, it is less clear how WAT inflammation is initiated. Here, we show that ATMs isolated from obese mice and humans exhibit markers of increased rate of de novo phosphatidylcholine (PC) biosynthesis. Macrophage-specific knockout of phosphocholine cytidylyltransferase A (CCTa), the rate-limiting enzyme of de novo PC biosynthesis pathway, alleviated obesity-induced WAT inflammation and insulin resistance. Mechanistically, CCTa-deficient macrophages showed reduced ER stress and inflammation in response to palmitate. Surprisingly, this was not due to lower exogenous palmitate incorporation into cellular PCs. Instead, CCTa-null macrophages had lower membrane PC turnover, leading to elevated membrane polyunsaturated fatty acid levels that negated the pro-inflammatory effects of palmitate. Our results reveal a causal link between obesity-associated increase in de novo PC synthesis, accelerated PC turnover and pro-inflammatory activation of ATMs.

Data availability

We are submitting raw source data excel file for LC-MS lipidomics of Pcyt1a-deficient BMDMs, in both palmitate-treated and basal states (containing peak areas for each lipid species normalized to peak areas of respective internal standards) as Figure 6-source data 1.ATM microarray dataset (GSE36669) used in Figure 1 is already published and referenced in this manuscript.We are also submitting a list of differentially expressed genes detected by RNAseq in the eWAT of ob/ob bone marrow transplant mice, with a log (Fold change), log (CPM) and p value indicated for each gene as Supplementary file 2b.We have uploaded raw RNA sequencing data of liver macrophages isolated from WT and ob/ob mice in the NCBI database, under the following accession number: PRJNA541224.

The following data sets were generated
The following previously published data sets were used

Article and author information

Author details

  1. Kasparas Petkevicius

    Metabolic Research Laboratories, University of Cambridge, Cambridge, United Kingdom
    For correspondence
    kp416@medschl.cam.ac.uk
    Competing interests
    The authors declare that no competing interests exist.
  2. Sam Virtue

    Metabolic Research Laboratories, University of Cambridge, Cambridge, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  3. Guillaume Bidault

    Metabolic Research Laboratories, University of Cambridge, Cambridge, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  4. Benjamin Jenkins

    Metabolic Research Laboratories, University of Cambridge, Cambridge, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  5. Cankut Çubuk

    Clinical Bioinformatics Area, Fundacion Progreso y Salud, Sevilla, Spain
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-4646-0849
  6. Cecilia Morgantini

    Department of Medicine, Karolinska Institute, Stockholm, Sweden
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-3142-2508
  7. Myriam Aouadi

    Department of Medicine, Karolinska Institute, Stockholm, Sweden
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-6256-7107
  8. Joaquin Dopazo

    Clinical Bioinformatics Area, Fundacion Progreso y Salud, Sevilla, Spain
    Competing interests
    The authors declare that no competing interests exist.
  9. Mireille Serlie

    Department of Endocrinology and Metabolism, Amsterdam University Medical Center, Amsterdam, Netherlands
    Competing interests
    The authors declare that no competing interests exist.
  10. Albert Koulman

    Metabolic Research Laboratories, University of Cambridge, Cambridge, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  11. Antonio Vidal-Puig

    Metabolic Research Laboratories, University of Cambridge, Cambridge, United Kingdom
    For correspondence
    ajv22@medschl.cam.ac.uk
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-4220-9577

Funding

Wellcome (4-year PhD programme in Metabolic and Cardiovascular Disease)

  • Kasparas Petkevicius

British Heart Foundation (Programme Grant RG/18/7/33636)

  • Kasparas Petkevicius
  • Sam Virtue
  • Guillaume Bidault
  • Antonio Vidal-Puig

Wellcome (Strategic Award)

  • Kasparas Petkevicius
  • Sam Virtue
  • Guillaume Bidault
  • Antonio Vidal-Puig

Medical Research Council (MRC_MC_UU_12012/5)

  • Kasparas Petkevicius
  • Sam Virtue
  • Guillaume Bidault
  • Antonio Vidal-Puig

Medical Research Council (MRC_MC_UU_12012/2)

  • Kasparas Petkevicius
  • Sam Virtue
  • Guillaume Bidault
  • Antonio Vidal-Puig

Spanish Ministry of economy and competitiveness (SAF2017-88908-R)

  • Cankut Çubuk
  • Joaquin Dopazo

Swedish Research council (2015-03582)

  • Cecilia Morgantini
  • Myriam Aouadi

Strategic research program in Diabetes at Karolinska Institutet (M.A.)

  • Cecilia Morgantini
  • Myriam Aouadi

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: All animal protocols were conducted in accordance with the UK Home Office and Cambridge University ethical guidelines.

Human subjects: Human samples used for this work had been generated as part of another study, that has already been published and is referenced in our manuscript (de Weijer et al, 2013). This study had been conducted to the highest ethical standards, and the ethics statement is available in the published paper.

Copyright

© 2019, Petkevicius et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 5,206
    views
  • 623
    downloads
  • 53
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Kasparas Petkevicius
  2. Sam Virtue
  3. Guillaume Bidault
  4. Benjamin Jenkins
  5. Cankut Çubuk
  6. Cecilia Morgantini
  7. Myriam Aouadi
  8. Joaquin Dopazo
  9. Mireille Serlie
  10. Albert Koulman
  11. Antonio Vidal-Puig
(2019)
Accelerated phosphatidylcholine turnover in macrophages promotes adipose tissue inflammation in obesity
eLife 8:e47990.
https://doi.org/10.7554/eLife.47990

Share this article

https://doi.org/10.7554/eLife.47990

Further reading

    1. Cell Biology
    Joan Chang, Adam Pickard ... Karl E Kadler
    Research Article

    Collagen-I fibrillogenesis is crucial to health and development, where dysregulation is a hallmark of fibroproliferative diseases. Here, we show that collagen-I fibril assembly required a functional endocytic system that recycles collagen-I to assemble new fibrils. Endogenous collagen production was not required for fibrillogenesis if exogenous collagen was available, but the circadian-regulated vacuolar protein sorting (VPS) 33b and collagen-binding integrin α11 subunit were crucial to fibrillogenesis. Cells lacking VPS33B secrete soluble collagen-I protomers but were deficient in fibril formation, thus secretion and assembly are separately controlled. Overexpression of VPS33B led to loss of fibril rhythmicity and overabundance of fibrils, which was mediated through integrin α11β1. Endocytic recycling of collagen-I was enhanced in human fibroblasts isolated from idiopathic pulmonary fibrosis, where VPS33B and integrin α11 subunit were overexpressed at the fibrogenic front; this correlation between VPS33B, integrin α11 subunit, and abnormal collagen deposition was also observed in samples from patients with chronic skin wounds. In conclusion, our study showed that circadian-regulated endocytic recycling is central to homeostatic assembly of collagen fibrils and is disrupted in diseases.

    1. Cell Biology
    Chun-Wei Chen, Jeffery B Chavez ... Bruce J Nicholson
    Research Article Updated

    Endometriosis is a debilitating disease affecting 190 million women worldwide and the greatest single contributor to infertility. The most broadly accepted etiology is that uterine endometrial cells retrogradely enter the peritoneum during menses, and implant and form invasive lesions in a process analogous to cancer metastasis. However, over 90% of women suffer retrograde menstruation, but only 10% develop endometriosis, and debate continues as to whether the underlying defect is endometrial or peritoneal. Processes implicated in invasion include: enhanced motility; adhesion to, and formation of gap junctions with, the target tissue. Endometrial stromal (ESCs) from 22 endometriosis patients at different disease stages show much greater invasiveness across mesothelial (or endothelial) monolayers than ESCs from 22 control subjects, which is further enhanced by the presence of EECs. This is due to the enhanced responsiveness of endometriosis ESCs to the mesothelium, which induces migration and gap junction coupling. ESC-PMC gap junction coupling is shown to be required for invasion, while coupling between PMCs enhances mesothelial barrier breakdown.